Cargando…
The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis
3C-like proteinase of severe acute respiratory syndrome (SARS) coronavirus has been demonstrated to be a key target for drug design against SARS. The interaction between SARS coronavirus 3C-like (3CL) proteinase and an octapeptide interface inhibitor was studied by affinity capillary electrophoresis...
Autores principales: | Ding, Li, Zhang, Xin-Xiang, Wei, Ping, Fan, Keqiang, Lai, Luhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094366/ https://www.ncbi.nlm.nih.gov/pubmed/15935325 http://dx.doi.org/10.1016/j.ab.2005.04.027 |
Ejemplares similares
-
The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase()
por: Wei, Ping, et al.
Publicado: (2006) -
Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase
por: Fan, Keqiang, et al.
Publicado: (2004) -
The substrate specificity of SARS coronavirus 3C-like proteinase
por: Fan, Keqiang, et al.
Publicado: (2005) -
Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase
por: Li, Chunmei, et al.
Publicado: (2010) -
Only One Protomer Is Active in the Dimer of SARS 3C-like Proteinase
por: Chen, Hao, et al.
Publicado: (2006)